Pharmaceuticals and Healthcare Industry Reports: Business Monitor Store

Algeria Pharmaceuticals & Healthcare Report

Pub date: 10 Feb 2012 Africa / Algeria Pharmaceuticals & Healthcare Industry Report

BMI View: Algeria’s attractiveness to foreign drugmakers remains tarnished by the heightened political and security risks, despite its relatively attractive demographic and socio-economic profile. Ad... Read More

Web Price: $995

Argentina Pharmaceuticals & Healthcare Report

Pub date: 13 Mar 2012 Latin America / Argentina Pharmaceuticals & Healthcare Industry Report

BMI View: Measured in local currency and in US dollars, the value of Argentina's pharmaceutical market is expected to grow at double-digit rates over the five years to 2016, in large part due to inf... Read More

Web Price: $995

Australia Pharmaceuticals & Healthcare Report

Pub date: 04 May 2012 Asia / Australia Pharmaceuticals & Healthcare Industry Report

BMI View: Given the country's increasingly ageing population and the consequential rise in noncommunicable diseases, Australia is a highly attractive place for multinational companies despite lower ... Read More

Web Price: $995

Bahrain Pharmaceuticals & Healthcare Report

Pub date: 22 Mar 2012 Middle East / Bahrain Pharmaceuticals & Healthcare Industry Report

BMI View: Bahrain is a developed pharmaceutical market with patented drug spending accounting for over 83% of the total pharmaceutical expenditure in 2011. However, political unrest has dented invest... Read More

Web Price: $995

Bangladesh Pharmaceuticals & Healthcare Report

Pub date: 16 Mar 2012 Asia / Bangladesh Pharmaceuticals & Healthcare Industry Report

BMI View: Although the growth of Bangladesh's pharmaceutical market is expected to remain in double digits over the forecast period, some of the gains will be negated by high levels of inflation. Add... Read More

Web Price: $995

Belarus Pharmaceuticals & Healthcare Report

Pub date: 19 Apr 2012 Europe / Belarus Pharmaceuticals & Healthcare Industry Report

BMI View: We continue to believe the Belarusian pharmaceutical market has long-term potential due to the country's favourable geographic position, demographic profile and low per capita spending. No... Read More

Web Price: $995

Belgium Pharmaceuticals & Healthcare Report

Pub date: 02 Mar 2012 Europe / Belgium Pharmaceuticals & Healthcare Industry Report

BMI View: Belgium, much like most of the other regional markets, is expected to post negative year-onyear (y-o-y) value growth in its 2012 pharmaceutical sales because of patent expirations and the ... Read More

Web Price: $995

Brazil Pharmaceuticals & Healthcare Report

Pub date: 22 Mar 2012 Latin America / Brazil Pharmaceuticals & Healthcare Industry Report

BMI View: Brazil remains the most attractive emerging pharmaceutical market in the Americas due to its large population, strong consumer demand, increasing urbanisation and comparatively good drug r... Read More

Web Price: $995

Bulgaria Pharmaceuticals & Healthcare Report

Pub date: 02 Mar 2012 Europe / Bulgaria Pharmaceuticals & Healthcare Industry Report

BMI View: Bulgaria's pharmaceutical market will be under some pressure in 2012 due to a weakening economic outlook and the tightening of publicly funded healthcare services. However, we have broadly ... Read More

Web Price: $995

Cambodia Pharmaceuticals & Healthcare Report

Pub date: 12 Apr 2012 Asia / Cambodia Pharmaceuticals & Healthcare Industry Report

BMI View: The Association of Southeast Asia Nations (ASEAN) is becoming increasingly attractive to foreign investors given the association's plans to boost economic development through the ASEAN Eco... Read More

Web Price: $995

Canada Pharmaceuticals & Healthcare Report

Pub date: 16 Mar 2012 North America / Canada Pharmaceuticals & Healthcare Industry Report

BMI View: With Canada's economy set to weather the external storm, the outlook for the country's pharmaceutical market looks relatively stable. Over the longer-term an ageing population in this alrea... Read More

Web Price: $995

Central America Pharmaceuticals & Healthcare Report

Pub date: 18 May 2012 Global / Latin America Pharmaceuticals & Healthcare Industry Report

BMI View: As countries are expected to invest heavily in healthcare provision over the medium term, we forecast the pharmaceutical markets of the seven states that comprise Central America to represe... Read More

Web Price: $995

Chile Pharmaceuticals & Healthcare Report

Pub date: 05 Apr 2012 Latin America / Chile Pharmaceuticals & Healthcare Industry Report

BMI View: Chile's pharmaceutical market is expected to become an increasingly attractive proposition for multinational companies as regulatory and intellectual property (IP) environment improves and ... Read More

Web Price: $995

China Pharmaceuticals & Healthcare Report

Pub date: 22 Mar 2012 Asia / China Pharmaceuticals & Healthcare Industry Report

BMI View: 2012 is a very important year for the country as the government look to carry on their achievements following the healthcare reform in 2009. We highlight that the expansion of the National ... Read More

Web Price: $995

Colombia Pharmaceuticals & Healthcare Report

Pub date: 02 Mar 2012 Latin America / Colombia Pharmaceuticals & Healthcare Industry Report

BMI View: Colombia's pharmaceutical and healthcare markets will perform better than the regional average over the medium term due to its high urbanisation rate and population growth. Strong macroeco... Read More

Web Price: $995

Croatia Pharmaceuticals & Healthcare Report

Pub date: 19 Mar 2012 Europe / Croatia Pharmaceuticals & Healthcare Industry Report

BMI View: Based on Croatia's deteriorating macroeconomic outlook, combined with our expectations that the new Kukuriku coalition government will pursue more severe austerity measures and the fact th... Read More

Web Price: $995

Czech Republic Pharmaceuticals & Healthcare Report

Pub date: 05 Apr 2012 Europe / Czech Republic Pharmaceuticals & Healthcare Industry Report

BMI View: We retain our negative outlook for the pharmaceutical market in the Czech Republic, expecting a 1.8% contraction in its value in local currency terms in 2012, following the 1.0% year-onyear... Read More

Web Price: $995

East Africa Pharmaceuticals & Healthcare Report

Pub date: 30 Apr 2012 Global / Africa Pharmaceuticals & Healthcare Industry Report

BMI calculates that pharmaceutical expenditure in Sudan and South Sudan at final consumer prices reached SDG1.50bn (US$565mn) in 2011, equivalent to US$13.0 a person. The value of Sudan's pharmaceut... Read More

Web Price: $995

Egypt Pharmaceuticals & Healthcare Report

Pub date: 17 Feb 2012 Africa / Egypt Pharmaceuticals & Healthcare Industry Report

BMI View: While Egypt’s healthcare and pharmaceuticals industry outlook continues to be dominated by macroeconomic themes, such as currency depreciation and political risk stemming from the upcoming ... Read More

Web Price: $995

Estonia Pharmaceuticals & Healthcare Report

Pub date: 24 Feb 2012 Europe / Estonia Pharmaceuticals & Healthcare Industry Report

BMI View: Estonia’s pharmaceutical market will remain of marginal interest to multinationals, given its small population size and a modest growth outlook. We expect the market to post a five-year com... Read More

Web Price: $995

France Pharmaceuticals & Healthcare Report

Pub date: 02 Mar 2012 Europe / France Pharmaceuticals & Healthcare Industry Report

BMI View: Despite concerted progress made on the fiscal consolidation front in the first half of 2011, the French government's medium-term fiscal targets remain on the optimistic side, particularly g... Read More

Web Price: $995

Germany Pharmaceuticals & Healthcare Report

Pub date: 28 Feb 2012 Europe / Germany Pharmaceuticals & Healthcare Industry Report

BMI View: Despite the threat of austerity measures and the government's focus on cost-containment within the pharmaceuticals and healthcare sector, as well as the impact of generic competition as a r... Read More

Web Price: $995

Ghana Pharmaceuticals & Healthcare Report

Pub date: 05 Apr 2012 Africa / Ghana Pharmaceuticals & Healthcare Industry Report

BMI View: While Ghana's business environment is superior to that of almost all of its neighbours in West and Central Africa, its domestic market is relatively small and it still struggles to attract ... Read More

Web Price: $995

Greece Pharmaceuticals & Healthcare Report

Pub date: 05 Apr 2012 Europe / Greece Pharmaceuticals & Healthcare Industry Report

BMI View: The challenges facing drugmakers in Greece in 2012 will be considerably tougher than those faced in 2011. With the introduction of new cost-containment legislation in March 2012, the Greek ... Read More

Web Price: $995

Hong Kong Pharmaceuticals & Healthcare Report

Pub date: 02 Mar 2012 Asia / Hong Kong Pharmaceuticals & Healthcare Industry Report

BMI View: Despite an increasingly ageing population (consequently increasing burden of noncommunicable diseases) Hong Kong will only be moderately attractive to investors given its small market size... Read More

Web Price: $995

Hungary Pharmaceuticals & Healthcare Report

Pub date: 17 Feb 2012 Europe / Hungary Pharmaceuticals & Healthcare Industry Report

BMI View: Some changes have been made to the original March 2011 proposal to reduce costs in the pharmaceutical market, representing moderately good news for drugmakers. However, this development wi... Read More

Web Price: $995

India Pharmaceuticals & Healthcare Report

Pub date: 05 Apr 2012 Asia / India Pharmaceuticals & Healthcare Industry Report

BMI View: India's pharmaceutical market is highly attractive to drugmakers but it also has several negative characteristics. Combined sales of over-the-counter (OTC) and prescription medicines are e... Read More

Web Price: $995

Indonesia Pharmaceuticals & Healthcare Report

Pub date: 22 Mar 2012 Asia / Indonesia Pharmaceuticals & Healthcare Industry Report

BMI View: Indonesia is a high growth pharmaceutical market driven by rising domestic consumption and government spending on healthcare. Having said this, the prevalence of self-medication and generic... Read More

Web Price: $995

Iran Pharmaceuticals & Healthcare Report

Pub date: 17 Feb 2012 Middle East / Iran Pharmaceuticals & Healthcare Industry Report

BMI View: We continue viewing Iran as one of the less attractive regional markets. Imposition of more stringent international sanctions, rampant inflation, and the loss of confidence in the Iranian ri... Read More

Web Price: $995

Iraq Pharmaceuticals & Healthcare Report

Pub date: 13 Apr 2012 Middle East / Iraq Pharmaceuticals & Healthcare Industry Report

BMI View: The Iraqi government aims to encourage more foreign investment in the country's healthcare system, with a recent report suggesting the management and operation of hospitals and specialist c... Read More

Web Price: $995

Israel Pharmaceuticals & Healthcare Report

Pub date: 16 Mar 2012 Middle East / Israel Pharmaceuticals & Healthcare Industry Report

BMI View: Following widespread protests in mid-2011, the Israeli government has been under significant pressure to spend more on housing, healthcare and education. While it was not about to tear dow... Read More

Web Price: $995

Italy Pharmaceuticals & Healthcare Report

Pub date: 17 Feb 2012 Europe / Italy Pharmaceuticals & Healthcare Industry Report

BMI View: The pharmaceuticals and healthcare sector will be a target of further cost containment, particularly as National Health System (SSN) data for H111, which shows a decline in spending, highl... Read More

Web Price: $995

Japan Pharmaceuticals & Healthcare Report

Pub date: 24 Feb 2012 Asia / Japan Pharmaceuticals & Healthcare Industry Report

BMI View: Japan’s pharmaceutical market is proving to be a welcome refuge for the leading multinational drugmakers, which are experiencing austerity-induced revenue contractions in Western Europe an... Read More

Web Price: $995

Jordan Pharmaceuticals & Healthcare Report

Pub date: 17 Feb 2012 Middle East / Jordan Pharmaceuticals & Healthcare Industry Report

BMI View: Regionally speaking, Jordan’s pharmaceutical market will continue to be viewed as a moderately attractive destination for foreign drugmakers. The country has a well-developed local pharmac... Read More

Web Price: $995

Kazakhstan Pharmaceuticals & Healthcare Report

Pub date: 02 Mar 2012 Europe / Kazakhstan Pharmaceuticals & Healthcare Industry Report

BMI View: Kazakhstan remains the most accessible and competitive pharmaceutical market in Central Asia and the growing expectation it will gain World Trade Organisation (WTO) membership by the end o... Read More

Web Price: $995

Kenya Pharmaceuticals & Healthcare Report

Pub date: 04 May 2012 Africa / Kenya Pharmaceuticals & Healthcare Industry Report

BMI View: The Kenyan government's focus on non-communicable disease awareness, prevention and treatment will increase the demand for chronic disease treatments in the country. To maximise returns on ... Read More

Web Price: $995

Kuwait Pharmaceuticals & Healthcare Report

Pub date: 16 Mar 2012 Middle East / Kuwait Pharmaceuticals & Healthcare Industry Report

BMI View: While Kuwait will continue to be of interest to multinational drugmakers - on account of traditional preference for branded medicines and the population's wealth - we caution that strengthe... Read More

Web Price: $995

Latvia Pharmaceuticals & Healthcare Report

Pub date: 04 May 2012 Europe / Latvia Pharmaceuticals & Healthcare Industry Report

BMI View: We have revised downwards our 2012 projections for the growth of the Latvian pharmaceutical market on account of weaker growth towards the end of 2011, combined with ongoing concerns over ... Read More

Web Price: $995

Lebanon Pharmaceuticals & Healthcare Report

Pub date: 16 Mar 2012 Middle East / Lebanon Pharmaceuticals & Healthcare Industry Report

BMI View: Continued improvement in Lebanon's intellectual property (IP) and pharmaceutical regulatory environment reinforces BMI's view that the country will begin to attract investment in a similar... Read More

Web Price: $995

Lithuania Pharmaceuticals & Healthcare Report

Pub date: 13 Apr 2012 Europe / Lithuania Pharmaceuticals & Healthcare Industry Report

BMI View: Lithuania's drug market is expected to post a gradual recovery over the next five years, but with a short-term worsening economic environment. Public and private consumption will be under ... Read More

Web Price: $995

Malaysia Pharmaceuticals & Healthcare Report

Pub date: 16 Mar 2012 Asia / Malaysia Pharmaceuticals & Healthcare Industry Report

BMI View: Malaysia's longer term potential as an attractive pharmaceutical market will remain shaped by the prevailing economic conditions and the export situation, which are crucial for the country'... Read More

Web Price: $995

Mexico Pharmaceuticals & Healthcare Report

Pub date: 18 May 2012 Latin America / Mexico Pharmaceuticals & Healthcare Industry Report

BMI View: Theoretically, Mexico offers one of the most favourable intellectual property (IP) environments in Latin America, which will continue to prop up multinational interest in the country’s pha... Read More

Web Price: $995

Moldova Pharmaceuticals & Healthcare Report

Pub date: 16 Mar 2012 Europe / Moldova Pharmaceuticals & Healthcare Industry Report

BMI View: Moldova's pharmaceutical market recorded stronger growth in 2011, but its small market size and its status as the poorest countries in Europe limit its attractiveness as a destination for ... Read More

Web Price: $995

Morocco Pharmaceuticals & Healthcare Report

Pub date: 05 Apr 2012 Africa / Morocco Pharmaceuticals & Healthcare Industry Report

BMI View: Morocco's pharmaceutical and healthcare market developments this year will be shaped by the delayed rollout of the national health insurance scheme. On the one hand, the programme is expect... Read More

Web Price: $995

Netherlands Pharmaceuticals & Healthcare Report

Pub date: 11 May 2012 Europe / Netherlands Pharmaceuticals & Healthcare Industry Report

BMI View: While the Netherlands is a low risk market from the point of view of multinational drugmakers, the country's modest per capita expenditure on pharmaceuticals relative to other Western Euro... Read More

Web Price: $995

New Zealand Pharmaceuticals & Healthcare Report

Pub date: 17 Feb 2012 Asia / New Zealand Pharmaceuticals & Healthcare Industry Report

BMI View: While New Zealand has a highly developed healthcare services system, its pharmaceutical market is not a particularly attractive prospect for multinationals. Even though the country’s risk p... Read More

Web Price: $995

Nigeria Pharmaceuticals & Healthcare Report

Pub date: 04 May 2012 Africa / Nigeria Pharmaceuticals & Healthcare Industry Report

BMI View: The Nigerian pharmaceutical market continues to be seen as a risky proposition to multinationals. While the country's oil revenues are significant, income distribution remains extremely un... Read More

Web Price: $995

Oman Pharmaceuticals & Healthcare Report

Pub date: 02 Mar 2012 Middle East / Oman Pharmaceuticals & Healthcare Industry Report

BMI View: Oman's 2012 budget allocated a greater sum of money to the healthcare sector, in line with BMI's view that the Arab spring would lead to greater spending in this segment. The Omani governm... Read More

Web Price: $995

Pakistan Pharmaceuticals & Healthcare Report

Pub date: 17 Feb 2012 Asia / Pakistan Pharmaceuticals & Healthcare Industry Report

BMI View: Despite the fact a significant number of multinationals are present in Pakistan, and the country's significant market potential, the leading international firms play a minimal role in the l... Read More

Web Price: $995

Peru Pharmaceuticals & Healthcare Report

Pub date: 16 Mar 2012 Latin America / Peru Pharmaceuticals & Healthcare Industry Report

BMI View: Peru's large and growing population underpins the potential of its pharmaceutical market, especially given the rising prevalence of non-communicable diseases. However, Peru remains listed o... Read More

Web Price: $995

Philippines Pharmaceuticals & Healthcare Report

Pub date: 02 Mar 2012 Asia / Philippines Pharmaceuticals & Healthcare Industry Report

BMI View: Much of the population in the Philippines still struggles to afford medicines, despite the enforcement of the Universally Accessible Cheaper and Quality Medicines Act of 2008 (previously kn... Read More

Web Price: $995

Poland Pharmaceuticals & Healthcare Report

Pub date: 02 Mar 2012 Europe / Poland Pharmaceuticals & Healthcare Industry Report

BMI View: It is worth reiterating our view that while 2012 is set to be a challenging year for drugmakers operating in Poland, we do not believe the impact of the Drug Reimbursement Act will lead to ... Read More

Web Price: $995

Portugal Pharmaceuticals & Healthcare Report

Pub date: 16 Mar 2012 Europe / Portugal Pharmaceuticals & Healthcare Industry Report

BMI View: Since the approval of an EU/ECB/IMF economic rescue package in May 2011, cost cutting measures have taken their toll on all sectors - including the pharmaceutical and healthcare industry. F... Read More

Web Price: $995

Puerto Rico Pharmaceuticals & Healthcare Report

Pub date: 16 Mar 2012 Caribbean / Puerto Rico Pharmaceuticals & Healthcare Industry Report

BMI View: Puerto Rico is struggling to retain its reputation as a pharmaceutical manufacturing hub, with a number of plants found to be in breach of regulations and standards over recent years. Addi... Read More

Web Price: $995

Qatar Pharmaceuticals & Healthcare Report

Pub date: 02 Mar 2012 Middle East / Qatar Pharmaceuticals & Healthcare Industry Report

BMI View: Following Qatar's decision to reintroduce controls on medicine prices in late 2011, we expect pharmaceutical price inflation to moderate. Consequently, market growth rates in 2012 will be a... Read More

Web Price: $995

Romania Pharmaceuticals & Healthcare Report

Pub date: 16 Mar 2012 Europe / Romania Pharmaceuticals & Healthcare Industry Report

BMI View: Following the resignation of Emil Boc and his government in February 2012, there is now considerable uncertainty with regard to reform of the Romanian healthcare sector. In particular, draf... Read More

Web Price: $995

Russia Pharmaceuticals & Healthcare Report

Pub date: 22 Mar 2012 Europe / Russia Pharmaceuticals & Healthcare Industry Report

BMI View: On the positive side, Russia's pharmaceutical market should regain double-digit US dollar growth from 2013 and the approval of the country's entry to the WTO should provide a clearer regul... Read More

Web Price: $995

Saudi Arabia Pharmaceuticals & Healthcare Report

Pub date: 30 Mar 2012 Middle East / Saudi Arabia Pharmaceuticals & Healthcare Industry Report

BMI View: In line with BMI's view that public healthcare spending in Saudi Arabia would be greatly boosted by government initiatives in 2012 there has been a flurry of activity in the public healthca... Read More

Web Price: $995

Serbia Pharmaceuticals & Healthcare Report

Pub date: 22 Mar 2012 Europe / Serbia Pharmaceuticals & Healthcare Industry Report

BMI View: Corruption continues to be a major problem within state healthcare services in Serbia. The government are taking measures to tackle the issue but the pharmaceutical industry is particularly... Read More

Web Price: $995

Singapore Pharmaceuticals & Healthcare Report

Pub date: 16 Mar 2012 Asia / Singapore Pharmaceuticals & Healthcare Industry Report

BMI View: Singapore is a well-developed pharmaceutical market, although overall sales only reached a modest SGD901mn (US$716mn) in 2011, on account of the small population of the city-state. Neverth... Read More

Web Price: $995

Slovakia Pharmaceuticals & Healthcare Report

Pub date: 03 Apr 2012 Europe / Slovakia Pharmaceuticals & Healthcare Industry Report

BMI View: The Slovakian pharmaceutical market will be shaped by the introduction of new, strict costcontainment measures, which include legislation designed to significantly lower drug prices. The p... Read More

Web Price: $995

Slovenia Pharmaceuticals & Healthcare Report

Pub date: 17 Feb 2012 Europe / Slovenia Pharmaceuticals & Healthcare Industry Report

BMI View: Slovenia's pharmaceutical market outlook remains broadly unchanged in our Q212 assessment. While weak economic data and revised forecasts have led us to adjust our drug market projections ... Read More

Web Price: $995

South Africa Pharmaceuticals & Healthcare Report

Pub date: 13 Apr 2012 Africa / South Africa Pharmaceuticals & Healthcare Industry Report

BMI View: South Africa is one of the most developed markets in the region from a business environment and regulatory standpoint. However, vast income disparity within the population has created a two... Read More

Web Price: $995

South Korea Pharmaceuticals & Healthcare Report

Pub date: 17 Feb 2012 Asia / South Korea Pharmaceuticals & Healthcare Industry Report

BMI View: While South Korea's research and development (R&D) environment may be attractive to investors, its pharmaceutical market environment is rather uncertain given the dispute between pharmaceu... Read More

Web Price: $995

Southern Africa Pharmaceuticals & Healthcare Report

Pub date: 12 Mar 2012 Global / Africa Pharmaceuticals & Healthcare Industry Report

Angola BMI View: Angola's pharmaceutical and healthcare market is characterised by a weak regulatory framework, a lack of intellectual property (IP) protection, an abundance of fake drugs, a degree ... Read More

Web Price: $995

Spain Pharmaceuticals & Healthcare Report

Pub date: 16 Mar 2012 Europe / Spain Pharmaceuticals & Healthcare Industry Report

BMI View: Companies with significant exposure to debt-ridden European markets will be hard hit by government austerity measures across the region, particularly by pharmaceutical price erosion mechan... Read More

Web Price: $995

Sri Lanka Pharmaceuticals and Healthcare Report

Pub date: 19 Apr 2012 Asia / Sri Lanka Pharmaceuticals & Healthcare Industry Report

BMI View: While it is clear the implementation of a medicine pricing policy will help to control public pharmaceuticals and healthcare expenditure, we believe it is vital the Sri Lankan government en... Read More

Web Price: $995

Sudan & South Sudan Pharmaceuticals & Healthcare Report

Pub date: 20 Feb 2012 Africa / Sudan Pharmaceuticals & Healthcare Industry Report

BMI View: The short-term outlook for Sudan and South Sudan's pharmaceutical markets will be more dependent on the economic and political stability of the two countries, rather than their need for me... Read More

Web Price: $995

Sweden Pharmaceuticals & Healthcare Report

Pub date: 04 May 2012 Europe / Sweden Pharmaceuticals & Healthcare Industry Report

BMI View: Our five-year forecasts for the Swedish pharmaceutical market show a decline in its overall size, which is expected to fall to SEK42.02bn (US$5.64bn) by 2016. Key reasons for this pessimism... Read More

Web Price: $995

Switzerland Pharmaceuticals & Healthcare Report

Pub date: 16 Mar 2012 Europe / Switzerland Pharmaceuticals & Healthcare Industry Report

BMI View: The expected growth of the Switzerland's ageing population over the next 50 years will have an unprecedented impact on the demand for healthcare. The elderly require more medical check-ups ... Read More

Web Price: $995

Taiwan Pharmaceuticals & Healthcare Report

Pub date: 18 May 2012 Asia / Taiwan Pharmaceuticals & Healthcare Industry Report

BMI View: While high volume consumption of pharmaceuticals per capita will continue to draw multinationals to Taiwan, the country remains committed to cost-containment in the public healthcare spend... Read More

Web Price: $995

Thailand Pharmaceuticals & Healthcare Report

Pub date: 17 Feb 2012 Asia / Thailand Pharmaceuticals & Healthcare Industry Report

BMI View: Thailand is a moderately attractive pharmaceutical market for multinationals. On the positive side, rewards are potentially considerable, given the country’s epidemiological profile and the ... Read More

Web Price: $995

Turkey Pharmaceuticals & Healthcare Report

Pub date: 11 May 2012 Europe / Turkey Pharmaceuticals & Healthcare Industry Report

BMI View: Before 2010, Turkey's pharmaceutical market growth was rapidly driven by modernisation, growing investment and improving awareness about healthcare. Since 2009, Turkey's pharmaceutical ind... Read More

Web Price: $995

Ukraine Pharmaceuticals & Healthcare Report

Pub date: 22 Mar 2012 Europe / Ukraine Pharmaceuticals & Healthcare Industry Report

BMI View: While we continue to see huge potential in the Ukrainian pharmaceutical market, we are pessimistic with regard to short- and medium-term stability in the marketplace. In particular, we are ... Read More

Web Price: $995

United Arab Emirates Pharmaceuticals & Healthcare Report

Pub date: 13 Apr 2012 Middle East / United Arab Emirates Pharmaceuticals & Healthcare Industry Report

BMI View: New population data for 2011 show the size of the expatriate population in the United Arab Emirates (UAE) has been underappreciated. Population growth has fed into a rise in the World Heal... Read More

Web Price: $995

United Kingdom Pharmaceuticals & Healthcare Report

Pub date: 05 Apr 2012 Europe / United Kingdom Pharmaceuticals & Healthcare Industry Report

BMI View: While the strength of the UK's pharmaceutical manufacturing industry is significant, the sector will face considerable challenges over the coming years. Economic weakness, patent expiration... Read More

Web Price: $995

United States Pharmaceuticals & Healthcare Report

Pub date: 20 Mar 2012 North America / United States Pharmaceuticals & Healthcare Industry Report

BMI View: Economics and politics are increasingly exerting an influence on the US pharmaceutical market. This is in stark contrast to the late 1990s and early 2000s, when the business environment was... Read More

Web Price: $995

Uzbekistan Pharmaceuticals & Healthcare Report

Pub date: 17 Feb 2012 Europe / Uzbekistan Pharmaceuticals & Healthcare Industry Report

BMI View: Uzbekistan is Central Asia’s largest market by population, although its pharmaceutical market lags that of neighbouring Kazakhstan in value terms, with per capita spending on pharmaceutica... Read More

Web Price: $995

Venezuela Pharmaceuticals & Healthcare Report

Pub date: 12 Apr 2012 Latin America / Venezuela Pharmaceuticals & Healthcare Industry Report

BMI View: Venezuela's pharmaceutical industry will face increasingly harsh pricing policy which is unlikely to tackle the persistent medicine shortage problem. President Hugo Chávez's renewed attempt... Read More

Web Price: $995

Vietnam Pharmaceuticals & Healthcare Report

Pub date: 24 Apr 2012 Asia / Vietnam Pharmaceuticals & Healthcare Industry Report

BMI View: The attractiveness of the Vietnamese pharmaceutical market to foreign investors will continue to be hampered by the country's poor enforcement of intellectual property (IP) and the authori... Read More

Web Price: $995

West & Central Africa Pharmaceuticals & Healthcare Report

Pub date: 12 Mar 2012 Africa / Gabon Pharmaceuticals & Healthcare Industry Report

BMI View: The better regulated markets of the Gulf Cooperation Council (GCC), South Africa and Israel will remain the most rewarding and least risky for drugmakers operating in the Middle East and Af... Read More

Web Price: $995

Zimbabwe Pharmaceuticals & Healthcare Report

Pub date: 02 Mar 2012 Africa / Zimbabwe Pharmaceuticals & Healthcare Industry Report

BMI View: On account of its unpredictable and unfavourable operating environment and limited funding for and investment in healthcare and medicines, Zimbabwe's pharmaceutical market will remain unat... Read More

Web Price: $995